aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 0.00 (-2.82%)
As of: Oct 23, 2026 · 2:29 PM EDT

aTYR PHARMA (ATYR) Price to Sales (2020 - 2026)

Updated

aTYR PHARMA's (ATYR) Price to Sales came in at 402.53 for Q1 2026, unchanged from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Price to Sales (2020 - 2026) Analysis & Trends

For FY2025, aTYR PHARMA's Price to Sales stood at 402.44, down 68.9% from FY2024.

  • In prior years, aTYR PHARMA's Price to Sales was 1294.56 in FY2024 (+412.1%), 252.79 in FY2023 and 6.22 in FY2022.
  • The Q1 2026 figure stands as the highest quarterly Price to Sales since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,128.85 Bn 1,097.43 Bn 19.71 Bn
2 Johnson & Johnson 634.21 Bn 554.07 Bn 17.30 Bn
3 AbbVie 505.78 Bn 478.89 Bn 12.70 Bn
4 Merck 357.64 Bn 312.02 Bn 12.21 Bn
5 Novartis Ag 290.31 Bn 254.30 Bn 11.24 Bn
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn
7 Amgen 238.11 Bn 193.51 Bn 7.24 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn
10 aTYR PHARMA 16.20 Mn -276.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 402.53
Dec 31, 2025 402.44
Sep 30, 2025 371.32
Dec 31, 2024 1,294.56
Sep 30, 2024 567.78
Jun 30, 2024 201.09
Mar 31, 2024 226.68
Dec 31, 2023 252.79
Sep 30, 2023 8.62
Jun 30, 2023 11.86
Mar 31, 2023 8.47
Dec 31, 2022 5.19
Sep 30, 2022 39.54
Mar 31, 2022 62.80
Dec 31, 2020 3.40
Sep 30, 2020 3.78
Jun 30, 2020 4.85
Mar 31, 2020 2.27
API Access

aTYR PHARMA Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ATYR&period=max&api_key=YOUR_API_KEY